Adcytherix

Marseille, France

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

$122.4M raised

Oct 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Adcytherix raised?

Adcytherix has raised $122.4M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are Adcytherix's investors?

Adcytherix's investors include Bpifrance, RA Capital Management, Andera Partners, Kurma Partners, Pontifax.

Where is Adcytherix headquartered?

Adcytherix is headquartered in Marseille, France.

What does Adcytherix do?

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

What stage is Adcytherix at?

Adcytherix is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 16, 2025.

MLA

"Adcytherix — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/adcytherix. Accessed July 11, 2026.

APA

VCBacked. (2025). Adcytherix — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/adcytherix

Wikipedia (cite web)

{{cite web |title=Adcytherix — Funding & Investors |url=https://www.vcbacked.co/company/adcytherix |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 16, 2025.